| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | +1,939 | +20% | 11,420 | 04 May 2023 | Direct | F1 | ||
| transaction | OGN | Common Stock | Tax liability | $16,120 | -665 | -5.8% | $24.24 | 10,755 | 04 May 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -1,939 | -50% | $0.000000 | 1,940 | 04 May 2023 | Common Stock | 1,939 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | 1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024. |